Immunization with a Borrelia burgdorferi BB0172-derived peptide protects mice against lyme disease.
Lyme disease is the most prevalent arthropod borne disease in the US and it is caused by the bacterial spirochete Borrelia burgdorferi (Bb), which is acquired through the bite of an infected Ixodes tick. Vaccine development efforts focused on the von Willebrand factor A domain of the borrelial prote...
Main Authors: | Christina M Small, Dharani K Ajithdoss, Aline Rodrigues Hoffmann, Waithaka Mwangi, Maria D Esteve-Gassent |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3914939?pdf=render |
Similar Items
-
Identification of reactive Borrelia burgdorferi peptides associated with Lyme disease
by: Rafal Tokarz, et al.
Published: (2024-10-01) -
Evaluation of immunogenicity and efficacy of Borrelia burgdorferi derived peptide (PepB) antigen formulated in a protein scaffold in mice against Lyme disease
by: Wisam S. Hassan, et al.
Published: (2022-12-01) -
Borrelia PeptideAtlas: A proteome resource of common Borrelia burgdorferi isolates for Lyme research
by: Panga J. Reddy, et al.
Published: (2024-12-01) -
New BB0108, BB0126, BB0298, BB0323, and BB0689 Chromosomally Encoded Recombinant Proteins of <i>Borrelia burgdorferi</i> sensu lato for Serodiagnosis of Lyme Disease
by: Weronika Grąźlewska, et al.
Published: (2024-09-01) -
Borrelia burgdorferi sensu lato, the agent of Lyme borreliosis: life in the wilds
by: Gern L.
Published: (2008-09-01)